These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 19695805

  • 1. Dynamic susceptibility contrast perfusion MR imaging in distinguishing malignant from benign head and neck tumors: a pilot study.
    Razek AA, Elsorogy LG, Soliman NY, Nada N.
    Eur J Radiol; 2011 Jan; 77(1):73-9. PubMed ID: 19695805
    [Abstract] [Full Text] [Related]

  • 2. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
    Razek AA, Megahed AS, Denewer A, Motamed A, Tawfik A, Nada N.
    Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
    [Abstract] [Full Text] [Related]

  • 3. Role of perfusion magnetic resonance imaging in cervical lymphadenopathy.
    Abdel Razek AA, Gaballa G.
    J Comput Assist Tomogr; 2011 Apr; 35(1):21-5. PubMed ID: 21245685
    [Abstract] [Full Text] [Related]

  • 4. The role of time-resolved 3D contrast-enhanced MR angiography in the assessment and grading of cerebral arteriovenous malformations.
    Oleaga L, Dalal SS, Weigele JB, Hurst RW, Lee J, Voorhees A, Melhem ER.
    Eur J Radiol; 2010 Jun; 74(3):e117-21. PubMed ID: 19467814
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [Abstract] [Full Text] [Related]

  • 9. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA, Várallyay CG, Manninger S, Solymosi D, Haluska M, Hunt MA, Nesbit G, Stevens A, Jerosch-Herold M, Jacobs PM, Hoffman JM.
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [Abstract] [Full Text] [Related]

  • 10. Dynamic contrast-enhanced perfusion MR imaging with SPIO: a pilot study.
    Amemiya S, Akahane M, Aoki S, Abe O, Kamada K, Saito N, Ohtomo K.
    Invest Radiol; 2009 Sep; 44(9):503-8. PubMed ID: 19652616
    [Abstract] [Full Text] [Related]

  • 11. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S, Baghi M, Wagenblast J, Bisdas T, Thng CH, Mack MG, Koh TS, Ernemann U.
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
    Ozsunar Y, Mullins ME, Kwong K, Hochberg FH, Ament C, Schaefer PW, Gonzalez RG, Lev MH.
    Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
    Nishiura M, Yasuhiro T, Murase K.
    Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
    [Abstract] [Full Text] [Related]

  • 18. [Initial evaluation of mass lesions in the head and neck with enhanced (Gd-DTPA) MR imaging].
    Yu Q, Wang P, Shi H.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Nov; 33(6):347-9. PubMed ID: 11774438
    [Abstract] [Full Text] [Related]

  • 19. Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data.
    Ishida M, Sakuma H, Murashima S, Nishida J, Senga M, Kobayasi S, Takeda K, Kato N.
    J Magn Reson Imaging; 2009 Jan; 29(1):205-10. PubMed ID: 19097094
    [Abstract] [Full Text] [Related]

  • 20. Assessment of chronic renal allograft nephropathy using contrast-enhanced MRI: a pilot study.
    Pereira RS, Gonul II, McLaughlin K, Yilmaz S, Mahallati H.
    AJR Am J Roentgenol; 2010 May; 194(5):W407-13. PubMed ID: 20410386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.